You just read:

Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors

News provided by

Celtic Pharmaceutical Holdings L.P.

Apr 22, 2010, 08:00 ET